Infectious diseases with their host-parasite interactions represent a complex system involving components and processes that operate at different levels of time, space, and biological organization [19]. Infectious disease dynamics involve thousands of molecules, complicated interactions of the pathogen with the host and also with the environment. Therefore, to understand disease dynamics in-depth, one must understand the processes at these different levels of manifestation of infectious diseases, and the interactions between these levels. The two most studied scales in the transmission of infectious disease systems are the within-host and between-host scales. Although these models have provided useful information about virus-cell interactions at the level of a single host and disease transmission between hosts, disease modelers see the need to integrate or link these models to obtain a better understanding of the dynamics of infectious disease spread.
Several studies on infectious diseases have shown that disease transmission depends on within-host processes [2,14,21,23,24,31,37]. In particular, these studies have shown that the transmission potential of an infected host depends on the pathogen load and increases with increasing pathogen load. The different functional relationships between host infectivity and pathogen load have been identified. Studies of dengue and human immunodeficiency virus (HIV) transmission revealed a sigmoidal functional relationship between host infectivity and the pathogen load at the within-host level [31,37]. Studies that discuss similar functional relationships between host infectivity and pathogen load at the within-host scale include [23] for malaria and [24] for human T lymphotropic virus, [32] for visceral leishmaniasis and chikungunya, and [46] for hepatitis B. Over the past decade, the importance of multi-scale modeling of infectious disease dynamics has been increasingly recognized, and many mathematical models linking within-host and between-host processes have been developed. The multi-scale models for influenza infections can be found in [18,22]. In [17], the within-host model is nested within a broader epidemiological model by linking the transmission rate of the infection or the additional host mortality rate to the dynamics of the within-host model. In studies such as [2,14], a nested multi-scale model (NMSM) is developed that considers the transmission rate at the intermediate host level as a linear function of viral load. A multi-scale model is developed and used to evaluate the effectiveness of health interventions acting at different time scales in [16]. Using a similar dynamic approach, there is considerable interest in linking disease dynamics at within-host and between-host levels, such as in the study of HIV and hepatitis C virus [11,30]. The multi-scale models for influenza infections can be found in [18,22]. Multi-scale mathematical modeling studies of infectious diseases have expanded the landscape of disease modeling and have the potential to more accurately describe disease dynamics [33]. A thorough understanding of the infectious disease transmission requires knowledge of the processes at different levels of the infectious disease and of the interplay between these levels. To obtain a clear idea of the dynamics of the disease, different time scale models need to be integrated [2,14,21].
Multi-scale models of the infectious disease systems integrate the within-host scale and the between-host scale. There are five main different categories of multi-scale models that can be developed at different levels of organization of an infectious disease system, which are: individual-based multi-scale models (IMSMs), NMSMs, embedded multi-scale models (EMSMs), hybrid multi-scale models (HMSMs), and coupled multi-scale models (CMSMs) [15]. In IMSMs, the within-host sub-model is used to describe the entire infectious disease system across both the within-host scale and between-host scale. In case of NMSMs, there is only unidirectional flow of information (only from within-host scale sub-model to between-host scale sub-model). There is never, any reciprocal feedback from the between-host scale sub-model back down to the within-host scale sub-model. In contrast, EMSMs is both a top-down and bottom-up modeling approach where both the within-host scale sub-model and the between-host sub-model influence each other. In all the aforementioned three categories of multi-scale models, the within-host scale and the between-host scale belonged to the same domain and is modeled in a homogeneous way using the same formalism. But in case of HMSMs, the within-host scale and the between-host scale may no longer be modeled in a homogeneous way. The HMSMs are formed based on the multi-domain integration framework. The details of these categories can be found in [15].
Multi-scale modeling of COVID-19 disease is still in its infancy, and efforts are being made in this direction. Some of the available articles on multi-scale modeling can be found in [1,4,36,45]. A multi-scale model would be extremely helpful in understanding the spread of COVID-19 infection and evaluating the efficacy of the interventions not only at the individual level but also at the population level. Therefore, in this study, we develop an NMSM that integrates within-host and between-host sub-models. As the importance of multi-scale modeling in disease dynamics is increasingly recognized, we believe that our study contributes to the growing knowledge on multi-scale modeling of COVID-19 disease.
This article is organized as follows: in Section 2, we develop an NMSM, study the stability and bifurcation analysis, and numerically illustrate the theoretical results obtained. We also analyze the sensitivity of
The multi-scale model that we develop describes COVID-19 disease dynamics across two different time scales, i.e., the within-host scale and the between-host scale. The within-host scale model tracks the density of the pathogens and also the state of the host’s defense mechanisms, while the between-host scale model is concerned with the transmission of the disease within the host population. The multi-scale model consists of seven variables, namely, susceptible cells
-
(a)
The dynamics of the within-host scale variables are assumed to occur at a fast time scale
so thats ,U=U\left(s) , and{U}^{* }={U}^{* }\left(s) , while the dynamics of the between-host scale variables is assumed to occur at a slow time scaleV=V\left(s) so thatt ,S=S\left(t) ,I=I\left(t) , andE=E\left(t) . Because the infection obtains cleared within a few days, the value ofR=R\left(t) is non-zero only for a short period of time. Due to this, the within-host dynamics is considered only for a short period of time. But because the infection remains for longer time at the population level, the between-host dynamics is considered for a longer period of time.V\left(s) -
(b)
The transmission rate
and disease-induced death rate\beta at the between-host scale are assumed to be functions of viral load.d -
(c)
Immune response is captured in the model through the parameters
andx ; these parameters, respectively, denote the combined rates at which the infected cells and the virus are cleared by the release of cytokines and chemokines such as IL-6 TNF-y , INF-\alpha , CCL5, CXCL8 and CXCL10 [10].\alpha
Based on the aforementioned assumptions, the multi-scale model is described by the following system of differential equations:
Meanings of the parameters
| Parameters | Biological meaning |
|---|---|
|
| Natural birth rate of cells |
|
| Birth rate of human population |
|
| Burst rate of the virus |
|
| Natural death rate of human population |
|
| Natural death rate of cells |
|
| Natural death rate of virus |
|
| Infection rate of exposed population |
|
| Infection rate of susceptible cell |
|
| Recovery rate of the exposed and infected human population |
|
| Transmission rate of the susceptible human population |
|
| Rate at which the infected cells are cleared by the individual immune response |
|
| Rate at which the virus particles are cleared by the individual immune response |
|
| Death rate of the infected human population |
Based on the experimental observations of the impact of viral load on disease transmission [25] and disease-induced deaths, the linking of within-host and between-host sub-models is modeled by means of
The multi-scale model (2.8)–(2.13) is not that easy to analyze. The problem arises from the discrepancy between the time scales. The viral load
The viral load
We obtain the expression for
We note here that the entire within-host scale submodel is reduced to a single parameter
The existence, the positivity, and the boundedness of the solutions of the proposed models (2.18)–(2.20) need to be proved to ensure that the model has a mathematical and biological meaning.
Positivity and boundedness of the solutions of Systems (2.18)–(2.20) are proved in similar lines to the method discussed in [3,29].
Let
Let
Now, using the continuity of solution, for all of
Now, let us say that we have
Similarly, using the same analysis, we can show that
Thus, we find that
Let
Now,
We summarize the aforementioned discussion on boundedness by the following lemma.
The set
For the general first-order ordinary differential equation of the form
-
(i)
Under what conditions, solution exists for System (2.21)?
-
(ii)
Under what conditions, unique solution exists for System (2.21)?
Let D denote the domain:
(Existence of solution) Let D be the domain defined above such that (2.22) holds. Then, there exists a unique solution of model system of equations (2.18)–(2.20), which is bounded in the domain D.
Let
From equation (2.23), we have
Similarly, from equation (2.24), we have
Finally, from (2.25), we have
Hence, we have shown that all the partial derivatives are continuous and bounded. Therefore, Lipschitz condition (2.22) is satisfied. Hence, by Theorem 2.1, there exists a unique solution of Systems (2.18)–(2.20) in the region
The basic reproduction number denoted by
Systems (2.18)–(2.20) admit two equilibria, namely, the infection-free equilibrium
Since negative population does not make sense, the existence condition for the infected equilibrium point
We analyze the stability of equilibrium points
The Jacobian matrix of Systems (2.18)–(2.20) at the infection-free equilibrium
The characteristic equation of
The infection-free equilibrium point
To establish the global stability of the infection-free equilibrium
The infection-free equilibrium point
We will prove the global stability of
Comparing the general system to Systems (2.18)–(2.20), the functions
The infection-free equilibrium point is
The integrating factor is
Now, we will show that assumption
At
Thus, both Assumptions
The Jacobian matrix of Systems (2.18)–(2.20) at
The characteristic equation of the Jacobian
Clearly,
Simplifying the expression for
A unique infected equilibrium point
-
(i)
.{R}_{0}\gt 1 -
(ii)
.\left({A}_{1}{B}_{1}-{C}_{1})\gt 0
We use the method given by Castillo-Chavez and Song in [8] to do the bifurcation analysis.
In our case, we have
We know that
Let
With
The infection-free equilibrium point
Clearly,
Hence, we obtain the first eigenvalue of (2.31) as
The other eigenvalues
Substituting the expression for
The eigenvalues of (2.33) are
Hence, the matrix
Next, for proving Condition 2, we need to find the right and left eigenvectors of the zero eigenvalue (
By choosing
Therefore, the right eigen vector of zero eigenvalue is given by
Similarly, to find the left eigenvector
By choosing
Hence, the left eigen vector is given by
Now, we need to find
Expanding the summation in the expression for
Substituting these partial derivatives along with
Next, expanding the summation in the expression for
Now,
Hence,
Thus, we conclude that when
As
From the expression of
The basic reproduction number denoted by
To determine the best control measures, knowledge of the relative importance of the different factors responsible for transmission is useful. Initially, disease transmission is related to
The sign of the elasticity index tells whether
The elasticity index of
The elasticity indices calculated using the parameter values from Table 3 are given in Table 2. The elastic index of parameters
Elasticity indices of
| Parameters | Elastic index | Value |
|---|---|---|
|
|
| 1 |
|
|
| 1 |
|
|
| 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 0.0018 |
|
|
|
|
Now, we numerically illustrate the stability of the equilibrium points admitted by Systems (2.18)–(2.20). The simulation is done using MatLab software and ode solver ode45 is used to solve the system of equations. The parameter values of the within-host sub-model used in simulation are taken from [10]. These within-host parameter values are used in calculating the area under the viral load curve
Parameter values
| Symbols | Values | Source |
|---|---|---|
|
| 2 | [10] |
|
| 0.05 | [10] |
|
|
| [10] |
|
| 0.1 | [10] |
|
|
| [28] |
|
| 0.795 | [10] |
|
| 0.56 | [10] |
|
|
| [39] |
|
| 0.0115 | [39] |
|
| 0.062 | [34] |
|
| 0.09 | [39] |
|
| 0.0018 | [39] |
|
| 0.05, 0.0714 | [39] |
Initial values of the variables
| Variable | Initial values | Source |
|---|---|---|
|
|
| [10] |
|
| 0 | [10] |
|
| 5.2 | [10] |
|
| 1,000 | Assumed |
|
| 100 | Assumed |
|
| 50 | Assumed |
Taking


Global asymptotic stability of
We know that the infected equilibrium


Here, we vary two parameters of the model (2.18)–(2.20) at a time in a certain interval and plot the value of
Heat plot varying

Heat plots for parameters
Heat plot varying

Heat plots for parameters
Heat plot varying

Heat plots for parameters

Heat plots for parameters
In this section, we study the influence of the within-host sub-model parameters on the between-host sub-model variables. The reduced multi-scale model (2.18)–(2.20) is categorized as an NMSM according to the categorization of multi-scale model infectious disease systems [15]. Therefore, the multi-scale model (2.18)–(2.20) is unidirectionally coupled. In this only the within-host scale sub-model influences the between-host scale sub-model without any reciprocal feedback. Here, we illustrate the influence of the key within-host scale sub-model parameters such as
In Figure 9, the effect of variation of burst rate of virus on infected population is plotted. The infected population

Effect of variation of burst rate of virus on infected population.
In Figure 10, the effect of variation of rate of clearance of infected cells by the immune system on infected population is plotted. The infected population

Effect of variation of rate of clearance of infected cells by the immune system on infected population.
In Figure 11, the effect of variation of rate of clearance of virus particles by the immune system on infected population is plotted. The infected population

Effect of variation of rate of clearance of virus by the immune system on infected population.
In this section, in similar lines to the study done in [16,36], we extend the work on the multi-scale model discussed in Section 2 by including health care interventions. In the context of infectious diseases, disease dynamics can cause a large difference between the performance of a health intervention at the individual level (within-host scale), which is easy to determine, and its performance at the population level (between-host scale), which is difficult to determine [16]. As a result, in situations where the effectiveness of a health intervention cannot be determined, health interventions with proven effectiveness may be recommended over those with potentially higher comparable effectiveness [16]. We use three health care interventions that are as follows:
1. Antiviral drugs:
-
(a)
Drugs such as remdesivir inhibit RNA-dependent RNA polymerase, and drugs lopinavir and ritonavir inhibit the viral protease, thereby reducing viral replication [41]. Considering that these antiviral drugs are administered, the burst rate of the within-host scale sub-model
now gets modified to\alpha , where\alpha \left(1-\varepsilon ) is the efficacy of antiviral drugs and\varepsilon 0\lt \varepsilon \lt 1. -
(b)
HCQ acts by preventing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from binding to cell membranes and also chloroquine/HCQ could inhibit viral entry by acting as inhibitors of the biosynthesis of sialic acids, critical actors of virus–cell ligand recognition [38]. The administration of this drug decreases the infection rate
of susceptible cells. This parameter gets modified to becomek , wherek\left(1-\gamma ) is the efficacy of these drugs and\gamma .0\lt \gamma \lt 1
2. Immunomodulators:
Interferons are broad-spectrum antivirals, exhibiting both direct inhibitory effect on viral replication and supporting an immune response to clear virus infection [43]. Due to the administration of immunomodulators such as INF, immunity power of an individual increases as a result of which the clearance rate of infected cells and virus particles by immune response increases. Therefore, the parameters
3. Generalized social distancing:
This intervention involves introducing measures such as restriction of mass gatherings, wearing of mask, and temporarily closing schools. Assuming that generalized social distancing is introduced to control COVID-19 epidemic, then the rate of contact with community
Considering all the modifications in the parameters, the multi-scale model incorporating the effects of all the aforementioned health interventions becomes
The effective reproduction number after incorporating the health interventions is given by
Here, the comparative effectiveness of the aforementioned three health interventions are evaluated using
Percentage reduction of
We now consider eight different combinations of these three health interventions corresponding to efficacy values 0.3, 0.6, and 0.9 obtained using the effective reproductive number
Comparative effectiveness for
| No. | Indicator | % Age | CEL | % Age | CEM | % Age | CEH |
|---|---|---|---|---|---|---|---|
| 1 |
| 0 | 1 | 0 | 1 | 0 | 1 |
| 2 |
| 30 | 5 | 60 | 5 | 90 | 5 |
| 3 |
| 0.106 | 3 | 0.24 | 2 | 0.45 | 4 |
| 4 |
| 0.075 | 2 | 0.26 | 3 | 0.38 | 3 |
| 5 |
| 30.07 | 7 | 60.12 | 7 | 90.45 | 7 |
| 6 |
| 30.05 | 6 | 60.1 | 6 | 90.23 | 6 |
| 7 |
| 0.22 | 4 | 0.35 | 4 | 0.67 | 2 |
| 8 |
| 30.16 | 8 | 60.34 | 8 | 90.5 | 8 |
From Table 5, we deduce the following results regarding comparative effectiveness of three different interventions considered:
-
(a)
When a single intervention strategy is implemented, intervention involving introducing measures such as restriction of mass gatherings, wearing of mask, and temporarily closing schools show a significant decrease in
compared to the implementation of antiviral drugs and immunomodulators at all efficacy levels.{R}_{0} -
(b)
When considering two interventions, we observe that the generalized social distancing along with immunomodulators that boost the immune response would be highly effective in limiting the spread of infection in the community.
-
(c)
A combined strategy involving treatment with antiviral drugs, immunomodulators, and generalized social distancing seems to perform the best among all the combinations considered at all efficacy levels.
COVID-19 is a contagious respiratory and vascular disease caused by SARS-CoV-2. The emergence of the disease has posed a major challenge to health authorities and governments around the world. The COVID -19 has spread globally and is one of the largest pandemics the world has ever seen. Mathematical models have proved to provide useful information about the dynamics of the infectious diseases in the past. To understand the dynamics of the COVID-19 disease, several models have been developed and studied [6,9,12,27,35,39,40,44,47,48]. Although these models have provided useful information about the disease transmission, disease modelers see the need to integrate or link the models at different scales (within-host and between-host) to obtain a better understanding of the dynamics of infectious disease spread.
In this study, we develop an NMSM for COVID-19 disease that integrates the within-host scale and the between-host scale sub-models. The transmission rate and COVID-19-induced death rate at between-host scale are assumed to be a linear function of viral load. Because of the difficulties of working at two different time scales, we approximate individual-level host infectiousness by some surrogate measurable quantity called area under viral load and reduce the multi-scale model at two different times scales to a model with area under the viral load curve acting as a proxy of individual level host infectiousness.
Initially, the well-posedness of the reduced multi-scale model is discussed followed by the stability analysis of the equilibrium points admitted by the reduced multi-scale model. The infection-free equilibrium point of the model is found to remain globally asymptotically stable whenever the value of basic reproduction number is less than unity. As the value of basic reproduction number crossed unity, a unique infected equilibrium point exists and remains asymptotically stable if
We also use the reduced multi-scale model developed to study the comparative effectiveness of the three health interventions (antiviral drugs, immunomodulators, and generalized social distancing) for COVID-19 viral infection using
The study performed at multi-scale level in this study highlights the dependence of between-host processes on within-host processes. With the increasing recognition of the importance of multi-scale modeling in disease dynamics, we believe that our study contributes to the growing body of knowledge on multi-scale modeling of COVID-19 disease. Two categories of people benefit from the multi-scale study: disease modelers and public health officials. Disease modelers benefit from the fact that this study provides a different approach to modeling acute viral infections. For public health planners, this study provides a model-based approach to evaluating the effectiveness of public health interventions. We also believe that the results presented in this study will help physicians, doctors, and researchers in making informed decisions about COVID-19 disease prevention and treatment interventions.